Front Pediatr
January 2025
Introduction: Liver resection is a critical surgical option for managing benign and malignant tumors, including rare and complex cases in pediatric patients. While such procedures are well-documented in adults, the surgical management of large liver neoplasms in infants poses unique challenges due to anatomical and physiological considerations, as well as the limited number of cases reported globally.
Aim: This study aimed to describe the initial experiences with major hepatectomies in infants with large liver neoplasms at our center.
The shortage of donor organs remains an unresolved issue in livertransplantation worldwide. Consequently, strategies for expanding the donor pool are currently being developed. Donors meeting extended criteria undergo thorough evaluation, as livers obtained from marginal donors yield poorer outcomes in recipients, including exacerbated reperfusion injury, acute kidney injury, early graft dysfunction, and primary nonfunctioning graft.
View Article and Find Full Text PDFBackground: Living donor liver transplantation (LDLT) is an effective treatment for patients with end-stage liver disease. This study was performed to evaluate the outcomes of the initial series of LDLT procedures performed in the Republic of Uzbekistan and to demonstrate that liver transplantation is viable under the conditions in this country.
Methods: Between October 2021 and December 2023, we performed 40 LDLTs.
Background: Impairment of hepatic arterial flow including hepatic arterial thrombosis (HAT), hepatic arterial stenosis (HAS), and splenic artery steal syndrome (SASS) is potentially life-threatening complications. The proposed early diagnosis and urgent treatment strategy of graft arterial flow reduction aim to decrease morbidity and mortality.
Methods: Pediatric patients with known hepatic arterial flow impairment were retrospectively reviewed.
Introduction: In conditions of limited experience of pediatric simultaneous liver-kidney transplantation (SLKT) using grafts from living and deceased donors, there is a certain need to validate the approach.
Patients: The retrospective study of 18 pediatric patients who received SLKT between 2008 and 2019.
Results: Grafts were obtained from both living and deceased donors.